11
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Assessment of the efficacy and acceptability of an acebutolol/ hydkhlorothiazide combination in the treatment of mild to moderate essential hypertension

, &
Pages 526-535 | Received 07 Aug 1981, Published online: 11 Aug 2008

References

  • Aoki V. S., Brody M. J. The effect of thiazides on the sympathetic nervous system of hypertensive rats. Arch. Intern. Pharmacodyn. Thér 1969; 177: 423–4341. Aoki V. S., Brody M. J. The effect of thiazides on the sympathetic nervous system of hypertensive rats. Arch. Intern. Pharmacodyn. Thér 1969; 177: 423–434
  • Buhler F. R., Laragh J. H., Baer L. Propranolol inhibition of renin secretion: a specific approach to diagnosis and treatment of renin-dependent hypertensive disease. N. Engl. J. Med 1972; 287: 1209–12142. Buhler F. R., Laragh J. H., Baer L. Propranolol inhibition of renin secretion: a specific approach to diagnosis and treatment of renin-dependent hypertensive disease. N. Engl. J. Med 1972; 287: 1209–1214
  • Gatley M. S. To be taken as directed. J. R. Coll. Gen. Pract 1968; 16: 393. Gatley M. S. To be taken as directed. J. R. Coll. Gen. Pract 1968; 16: 39
  • Hollander W., Wilkins R. W. Chlorothiazide: a new type of drug for the treatment of arterial hypertension. Boston Med. Quart 1957; 8: 694. Hollander W., Wilkins R. W. Chlorothiazide: a new type of drug for the treatment of arterial hypertension. Boston Med. Quart 1957; 8: 69
  • Keith N. M., Wagener H. P., Barker N. W. Some different types of essential hypertension: their cause and prognosis. Am. J. Med. Sri 1939; 197: 3325. Keith N. M., Wagener H. P., Barker N. W. Some different types of essential hypertension: their cause and prognosis. Am. J. Med. Sri 1939; 197: 332
  • May and Baker Ltd. ‘Sectral’: an open short-term comparative study of ‘Sectral’ alone, of hydrochlorothiazide alone, and of the two drugs combined in the treatment of hypertension. Unpublished report 19816. May and Baker Ltd. ‘Sectral’: an open short-term comparative study of ‘Sectral’ alone, of hydrochlorothiazide alone, and of the two drugs combined in the treatment of hypertension. Unpublished report 1981
  • May and Baker Ltd. ‘Sectral’: an open short-term crossover study of the potentiation of ‘Sectral’ by hydrochlorothiazide in doses of 25, 50 or 100 mg in the management of hypertension. Unpublished report 19817. May and Baker Ltd. ‘Sectral’: an open short-term crossover study of the potentiation of ‘Sectral’ by hydrochlorothiazide in doses of 25, 50 or 100 mg in the management of hypertension. Unpublished report 1981
  • May and Baker Ltd. ‘Sectral’ hydrochlorothiazide: a comparative study of the concurrent oral administration of three dose combinations of ‘Sectral’ and hydrochlorothiazide in the treatment of mild to moderate hypertension. Unpublished report 19818. May and Baker Ltd. ‘Sectral’ hydrochlorothiazide: a comparative study of the concurrent oral administration of three dose combinations of ‘Sectral’ and hydrochlorothiazide in the treatment of mild to moderate hypertension. Unpublished report 1981
  • Tarazi R. C., Dustan H. P., Frohlich E. D. Long-term thiazide therapy in essential hypertension. Circulation 1970; 41: 709–7179. Tarazi R. C., Dustan H. P., Frohlich E. D. Long-term thiazide therapy in essential hypertension. Circulation 1970; 41: 709–717
  • Tobian L. Why do diuretics lower blood pressure in essential hypertension?. Annu. Rev. Pharmacol 1967; 7: 399–40810. Tobian L. Why do diuretics lower blood pressure in essential hypertension?. Annu. Rev. Pharmacol 1967; 7: 399–408

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.